WallStreetZenWallStreetZen

NASDAQ: POAI
Predictive Oncology Inc Stock Ownership - Who owns Predictive Oncology?

Insider buying vs selling

Have Predictive Oncology Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Robert L. MyersCHIEF FINANCIAL OFFICER2023-09-25510$2.96
$1.51kSell
Charles Lee Nuzum Sr.Director2023-09-2510,000$3.04
$30.39kSell

1 of 1

POAI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when POAI insiders and whales buy or sell their stock.

POAI Shareholders

What type of owners hold Predictive Oncology Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Joshua Kornberg1,804.87%73,329,247$121.73MInsider
Sok Partners LLC1,749.61%71,083,929$118.00MInsider
Samuel Herschkowitz1,582.53%64,295,862$106.73MInsider
Caron Partners LP117.80%4,786,082$7.94MInsider
Chad A. Ruwe70.02%2,844,964$4.72MInsider
Arnon I. Dreyfuss53.38%2,168,572$3.60MInsider
Carl I. Schwartz42.13%1,711,742$2.84MInsider
James E. Dauwalter25.49%1,035,572$1.72MInsider
J. Melville Engle10.26%416,693$691.71kInsider
Kevin R. Davidson8.12%329,927$547.68kInsider

1 of 3

POAI vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
POAI0.16%99.84%Net Selling
AVGR1.27%98.73%Net Selling
STSS8.84%23.64%Net BuyingNet Buying
LUCY0.95%38.06%
GCTK2.33%12.58%Net BuyingNet Buying

Predictive Oncology Stock Ownership FAQ

Who owns Predictive Oncology?

Predictive Oncology (NASDAQ: POAI) is owned by 9.04% institutional shareholders, 5,490.98% Predictive Oncology insiders, and 0.00% retail investors. Joshua Kornberg is the largest individual Predictive Oncology shareholder, owning 73.33M shares representing 1,804.87% of the company. Joshua Kornberg's Predictive Oncology shares are currently valued at $110.73M.

If you're new to stock investing, here's how to buy Predictive Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.